187 related articles for article (PubMed ID: 966144)
1. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
Dreyfuss J; Shaw JM; Ross JJ
J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
[TBL] [Abstract][Full Text] [Related]
2. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of the depot antipsychotics.
Jann MW; Ereshefsky L; Saklad SR
Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
[TBL] [Abstract][Full Text] [Related]
5. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
Luo JP; Hubbard JW; Midha KK
Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
[TBL] [Abstract][Full Text] [Related]
7. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
8. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.
Dreyfuss J; Ross JJ; Schreiber EC
J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931
[No Abstract] [Full Text] [Related]
9. Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.
Altamura AC; Whelpton R; Curry SH
Biopharm Drug Dispos; 1979; 1(2):65-72. PubMed ID: 552863
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Methods for study of fluphenazine kinetics in man.
Whelpton R; Curry SH
J Pharm Pharmacol; 1976 Dec; 28(12):869-73. PubMed ID: 12260
[TBL] [Abstract][Full Text] [Related]
12. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S
Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
14. [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].
Levron JC; Ropert R
Encephale; 1987; 13(2):83-7. PubMed ID: 2885172
[TBL] [Abstract][Full Text] [Related]
15. The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.
Luo JP; Hubbard JW; Midha KK
Pharm Res; 1998 Sep; 15(9):1485-9. PubMed ID: 9755905
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
